Unity Biotechnology, Inc. (UBX)

NASDAQ: UBX · Real-Time Price · USD

0.9601

-0.0799 (-7.68%)

At close: Apr 1, 2025, 4:00 PM

1.000

+0.040 (4.16%)

After-hours: Apr 1, 2025, 4:20 PM EDT

Unity Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Revenue	-	-	0.24	4.78	-	Upgrade
Revenue Growth (YoY)	-	-	-95.07%	-	-	Upgrade
Cost of Revenue	13.01	19.7	35.46	38.39	67.31	Upgrade
Gross Profit	-13.01	-19.7	-35.22	-33.61	-67.31	Upgrade
Selling, General & Admin	15.46	18.77	20.45	23.06	24.03	Upgrade
Operating Expenses	15.46	18.77	20.45	23.06	24.03	Upgrade
Operating Income	-28.47	-38.47	-55.67	-56.67	-91.33	Upgrade
Interest Expense	-	-2.45	-3.56	-3.18	-1.29	Upgrade
Interest & Investment Income	1.73	2.87	1.22	0.1	1.2	Upgrade
Other Non Operating Income (Expenses)	3.45	4.39	15.44	-1.11	-0.32	Upgrade
EBT Excluding Unusual Items	-23.29	-33.66	-42.57	-60.85	-91.75	Upgrade
Merger & Restructuring Charges	-	-0.6	-1.9	-	-2.63	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-	0.5	Upgrade
Asset Writedown	-2.71	-5.6	-	-	-	Upgrade
Other Unusual Items	-	-	-	0.12	0.03	Upgrade
Pretax Income	-25.99	-39.86	-44.47	-60.73	-93.84	Upgrade
Earnings From Continuing Operations	-25.99	-39.86	-44.47	-60.73	-93.84	Upgrade
Net Income	-25.99	-39.86	-44.47	-60.73	-93.84	Upgrade
Net Income to Common	-25.99	-39.86	-44.47	-60.73	-93.84	Upgrade
Shares Outstanding (Basic)	17	15	9	6	5	Upgrade
Shares Outstanding (Diluted)	17	15	9	6	5	Upgrade
Shares Change (YoY)	13.90%	55.60%	70.10%	9.73%	16.60%	Upgrade
EPS (Basic)	-1.54	-2.70	-4.68	-10.88	-18.45	Upgrade
EPS (Diluted)	-1.54	-2.70	-4.68	-10.88	-18.45	Upgrade
Free Cash Flow	-20.87	-37.1	-52.51	-45.26	-78.98	Upgrade
Free Cash Flow Per Share	-1.24	-2.51	-5.53	-8.11	-15.53	Upgrade
Operating Margin	-	-	-23589.83%	-1184.47%	-	Upgrade
Profit Margin	-	-	-18842.80%	-1269.34%	-	Upgrade
Free Cash Flow Margin	-	-	-22250.00%	-945.97%	-	Upgrade
EBITDA	-27.6	-37.28	-53.49	-53.79	-87.89	Upgrade
D&A For EBITDA	0.87	1.18	2.18	2.88	3.45	Upgrade
EBIT	-28.47	-38.47	-55.67	-56.67	-91.33	Upgrade

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q